Health regulator gives nod to Sinopharm shot for Covid-19
Authorisation is based on acceptable safety, quality and efficacy data submitted by manufacturer MC Pharma, Sahpra says
07 February 2022 - 09:27
The SA health regulator has registered Chinese Covid-19 vaccine Sinopharm, effectively clearing the way for its use in the country.
“This authorisation is based on acceptable safety, quality and efficacy data submitted by MC Pharma,” the SA Health Products Regulatory Authority (Sahpra) said in a statement...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.